Evaluation of Crypt Apoptotic Bodies and Apoptotic Indices in Pediatric Celiac Disease by Routine Staining and H2AX Immunostaining

Overview

Journal Int J Immunopathol Pharmacol

Publisher Sage Publications

Specialties Allergy & Immunology
Pathology
Pharmacology

Date 2021 Jun 17

PMID 34137295

Citations 4

Authors

Sarah Adel Hakim

Dalia Abd El-Kareem

Affiliations

Soon will be listed here.

Abstract

Celiac disease (CD) is an immune-mediated disorder with premature apoptosis occurring along the entire crypt-villous axis. H2AX is the end product of the intrinsic apoptotic pathway. This is the first study to assess apoptotic body counts (ABC) by H&E and apoptotic indices (AI) by immunohistochemistry (IHC) in pediatric CD. The aim of the current study was to evaluate ABC in pediatric patients with CD prior to and following institution of a gluten free diet (GFD). Sixty-three pediatric endoscopic duodenal samples were assessed and divided into three groups. A total of 21 samples from treatment naïve CD patients, 21 from the same patients after instituting a GFD, and 21 from non-celiac patients as a control group. Histopathological evaluation of ABC by H&E, and immunohistochemistry assessment of apoptotic indices (AI) by H2AX antibody were performed. The mean maximum ABC and AI were significantly higher in treatment naïve CD than in GFD and control samples. These values were also significantly higher in treatment naïve Marsh 3C (flat) than in Marsh 1, 2, 3A, and 3B (non-flat) CD cases. GFD samples with persistent flat lesions had significantly higher ABC and AI than GFD non-flat cases. ROC analysis of the mean maximum ABC and AI of treatment naïve CD cases had a statistically significant predictive potential for persistent villous atrophy at a cut-off level ⩾6.61 ( = 0.008) and ⩾105.4 ( = 0.003), respectively. Histopathological evaluation of crypt apoptotic bodies could provide predictive potential for continued villous atrophy following GFD.

Citing Articles

Tailoring of apoptotic bodies for diagnostic and therapeutic applications:advances, challenges, and prospects.

Miao X, Wu X, You W, He K, Chen C, Pathak J J Transl Med. 2024; 22(1):810.

PMID: 39218900 PMC: 11367938. DOI: 10.1186/s12967-024-05451-w.

Intraepithelial lymphocytes are associated with epithelial injury in feline intestinal T-cell lymphoma.

Ii T, Chambers J, Nakashima K, Goto-Koshino Y, Uchida K J Vet Med Sci. 2023; 86(1):101-110.

PMID: 38072403 PMC: 10849855. DOI: 10.1292/jvms.23-0339.

Advances in biological functions and applications of apoptotic vesicles.

Zou X, Lei Q, Luo X, Yin J, Chen S, Hao C Cell Commun Signal. 2023; 21(1):260.

PMID: 37749626 PMC: 10519056. DOI: 10.1186/s12964-023-01251-9.

Apoptotic bodies: bioactive treasure left behind by the dying cells with robust diagnostic and therapeutic application potentials.

Yu L, Zhu G, Zhang Z, Yu Y, Zeng L, Xu Z J Nanobiotechnology. 2023; 21(1):218.

PMID: 37434199 PMC: 10337089. DOI: 10.1186/s12951-023-01969-1.

References

Prieto A, Diaz D, Barcenilla H, Garcia-Suarez J, Reyes E, Monserrat J . Apoptotic rate: a new indicator for the quantification of the incidence of apoptosis in cell cultures. Cytometry. 2002; 48(4):185-93. DOI: 10.1002/cyto.10132. View

Miura N, Yamamoto M, Fukutake M, Ohtake N, Iizuka S, Ishige A . Anti-CD3 induces bi-phasic apoptosis in murine intestinal epithelial cells: possible involvement of the Fas/Fas ligand system in different T cell compartments. Int Immunol. 2005; 17(5):513-22. DOI: 10.1093/intimm/dxh231. View

Dickey J, Redon C, Nakamura A, Baird B, Sedelnikova O, Bonner W . H2AX: functional roles and potential applications. Chromosoma. 2009; 118(6):683-92. PMC: 3094848. DOI: 10.1007/s00412-009-0234-4. View

Ma Q, Liang M, Wu Y, Ding N, Duan L, Yu T . Mature osteoclast-derived apoptotic bodies promote osteogenic differentiation via RANKL-mediated reverse signaling. J Biol Chem. 2019; 294(29):11240-11247. PMC: 6643026. DOI: 10.1074/jbc.RA119.007625. View

Shalimar D, Das P, Sreenivas V, Gupta S, Panda S, Makharia G . Mechanism of villous atrophy in celiac disease: role of apoptosis and epithelial regeneration. Arch Pathol Lab Med. 2013; 137(9):1262-9. DOI: 10.5858/arpa.2012-0354-OA. View

Shulman H, Cardona D, Greenson J, Hingorani S, Horn T, Huber E . NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report. Biol Blood Marrow Transplant. 2015; 21(4):589-603. PMC: 4359636. DOI: 10.1016/j.bbmt.2014.12.031. View

Watson A . Necrosis and apoptosis in the gastrointestinal tract. Gut. 1995; 37(2):165-7. PMC: 1382710. DOI: 10.1136/gut.37.2.165. View

Marks C, Stadler M, Hausermann P, Wolff D, Buchholz S, Stary G . German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD. Br J Dermatol. 2011; 165(1):18-29. DOI: 10.1111/j.1365-2133.2011.10360.x. View

Phan T, Ozkocak D, Ho Poon I . Unleashing the therapeutic potential of apoptotic bodies. Biochem Soc Trans. 2020; 48(5):2079-2088. PMC: 7609033. DOI: 10.1042/BST20200225. View

10.

Sung D, Iuga A, Kato T, Martinez M, Remotti H, Lagana S . Crypt apoptotic body counts in normal ileal biopsies overlap with graft-versus-host disease and acute cellular rejection of small bowel allografts. Hum Pathol. 2016; 56:89-92. DOI: 10.1016/j.humpath.2016.05.017. View

11.

Ehrmann Jr J, Kolek A, Kodousek R, Zapletalova J, Lisova S, Murray P . Immunohistochemical study of the apoptotic mechanisms in the intestinal mucosa during children's coeliac disease. Virchows Arch. 2003; 442(5):453-61. DOI: 10.1007/s00428-003-0794-2. View

12.

Jiang J, Mikami K, Venugopal S, Li Y, Torok N . Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways. J Hepatol. 2009; 51(1):139-48. PMC: 2765371. DOI: 10.1016/j.jhep.2009.03.024. View

13.

Monguzzi E, Marabini L, Elli L, Vaira V, Ferrero S, Ferretti F . Gliadin effect on the oxidative balance and DNA damage: An in-vitro, ex-vivo study. Dig Liver Dis. 2018; 51(1):47-54. DOI: 10.1016/j.dld.2018.06.020. View

14.

Schumann M, Siegmund B, Schulzke J, Fromm M . Celiac Disease: Role of the Epithelial Barrier. Cell Mol Gastroenterol Hepatol. 2017; 3(2):150-162. PMC: 5331784. DOI: 10.1016/j.jcmgh.2016.12.006. View

15.

Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders D, Cellier C . European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019; 7(5):583-613. PMC: 6545713. DOI: 10.1177/2050640619844125. View

16.

Parfitt J, Jayakumar S, Driman D . Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol. 2008; 32(9):1367-72. DOI: 10.1097/pas.0b013e31816bf3fe. View

17.

Lin J, Fan R, Zhao Z, Cummings O, Chen S . Is the presence of 6 or fewer crypt apoptotic bodies sufficient for diagnosis of graft versus host disease? A decade of experience at a single institution. Am J Surg Pathol. 2012; 37(4):539-47. DOI: 10.1097/PAS.0b013e318272c62a. View

18.

Giovannini C, Matarrese P, Scazzocchio B, Vari R, DArchivio M, Straface E . Wheat gliadin induces apoptosis of intestinal cells via an autocrine mechanism involving Fas-Fas ligand pathway. FEBS Lett. 2003; 540(1-3):117-24. DOI: 10.1016/s0014-5793(03)00236-9. View

19.

Lee M, Betman S, Iuga A, Yang H, Fleming J, Green P . An association between crypt apoptotic bodies and mucosal flattening in celiac disease patients exposed to dietary gluten. Diagn Pathol. 2019; 14(1):98. PMC: 6717634. DOI: 10.1186/s13000-019-0878-1. View

20.

Kreft A, Mottok A, Mesteri I, Cardona D, Janin A, Kuhl A . Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility. Virchows Arch. 2015; 467(3):255-63. DOI: 10.1007/s00428-015-1803-y. View